Some studies have confirmed the downregulation of NDRG1 caused by DNA methylation of CpG islands of its promoter in breast cancer, prostate cancer cells and pancreatic cancer (Han, 2013; Li, 2015; Angst, 2010). Here, NDRG1 is linked to prostate cancer.